chr19-45350732-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_177417.3(KLC3):c.1364C>T(p.Ala455Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000135 in 1,612,064 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_177417.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
KLC3 | NM_177417.3 | c.1364C>T | p.Ala455Val | missense_variant | 11/13 | ENST00000391946.7 | |
ERCC2 | NM_000400.4 | c.*897G>A | 3_prime_UTR_variant | 23/23 | ENST00000391945.10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
KLC3 | ENST00000391946.7 | c.1364C>T | p.Ala455Val | missense_variant | 11/13 | 1 | NM_177417.3 | P4 | |
ERCC2 | ENST00000391945.10 | c.*897G>A | 3_prime_UTR_variant | 23/23 | 1 | NM_000400.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000921 AC: 14AN: 152072Hom.: 0 Cov.: 30
GnomAD3 exomes AF: 0.0000906 AC: 22AN: 242882Hom.: 0 AF XY: 0.0000906 AC XY: 12AN XY: 132462
GnomAD4 exome AF: 0.000140 AC: 204AN: 1459992Hom.: 0 Cov.: 34 AF XY: 0.000145 AC XY: 105AN XY: 726220
GnomAD4 genome AF: 0.0000921 AC: 14AN: 152072Hom.: 0 Cov.: 30 AF XY: 0.0000539 AC XY: 4AN XY: 74272
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 01, 2022 | The c.1364C>T (p.A455V) alteration is located in exon 11 (coding exon 10) of the KLC3 gene. This alteration results from a C to T substitution at nucleotide position 1364, causing the alanine (A) at amino acid position 455 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at